205 related articles for article (PubMed ID: 35743086)
1. Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, "Naked" Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells.
Varlamova EG; Goltyaev MV; Simakin AV; Gudkov SV; Turovsky EA
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743086
[TBL] [Abstract][Full Text] [Related]
2. Ca
Varlamova EG; Khabatova VV; Gudkov SV; Turovsky EA
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768736
[TBL] [Abstract][Full Text] [Related]
3. Cytoprotective Properties of a New Nanocomplex of Selenium with Taxifolin in the Cells of the Cerebral Cortex Exposed to Ischemia/Reoxygenation.
Varlamova EG; Khabatova VV; Gudkov SV; Plotnikov EY; Turovsky EA
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432668
[TBL] [Abstract][Full Text] [Related]
4. PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction.
Zheng S; Li X; Zhang Y; Xie Q; Wong YS; Zheng W; Chen T
Int J Nanomedicine; 2012; 7():3939-49. PubMed ID: 22915845
[TBL] [Abstract][Full Text] [Related]
5. Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.
Al-Noshokaty TM; Mesbah NM; Abo-Elmatty DM; Abulsoud AI; Abdel-Hamed AR
Life Sci; 2022 Aug; 303():120675. PubMed ID: 35640776
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis.
Varlamova EG; Goltyaev MV; Rogachev VV; Gudkov SV; Karaduleva EV; Turovsky EA
Cells; 2023 Nov; 12(23):. PubMed ID: 38067151
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the cytotoxic activity of sorafenib-loaded camel milk casein nanoparticles against hepatocarcinoma cells.
Mittal A; Mahala N; Dhanawade NH; Dubey SK; Dubey US
Biotechnol J; 2024 Mar; 19(3):e2300449. PubMed ID: 38472095
[TBL] [Abstract][Full Text] [Related]
8. Selenium nanoparticles fabricated in laminarin polysaccharides solutions exert their cytotoxicities in HepG2 cells by inhibiting autophagy and promoting apoptosis.
Cui D; Ma J; Liang T; Sun L; Meng L; Liang T; Li Q
Int J Biol Macromol; 2019 Sep; 137():829-835. PubMed ID: 31284007
[TBL] [Abstract][Full Text] [Related]
9. Green-Synthesized Silver and Selenium Nanoparticles Using Berberine: A Comparative Assessment of In Vitro Anticancer Potential on Human Hepatocellular Carcinoma Cell Line (HepG2).
Khaled AM; Othman MS; Obeidat ST; Aleid GM; Aboelnaga SM; Fehaid A; Hathout HMR; Bakkar AA; Moneim AEA; El-Garawani IM; Morsi DS
Cells; 2024 Feb; 13(3):. PubMed ID: 38334679
[TBL] [Abstract][Full Text] [Related]
10. Green synthesis of selenium nanoparticles with extract of hawthorn fruit induced HepG2 cells apoptosis.
Cui D; Liang T; Sun L; Meng L; Yang C; Wang L; Liang T; Li Q
Pharm Biol; 2018 Dec; 56(1):528-534. PubMed ID: 30387372
[TBL] [Abstract][Full Text] [Related]
11. Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy.
Zheng L; Li C; Huang X; Lin X; Lin W; Yang F; Chen T
Biomaterials; 2019 Sep; 216():119220. PubMed ID: 31200144
[TBL] [Abstract][Full Text] [Related]
12. Size-Dependent Cytoprotective Effects of Selenium Nanoparticles during Oxygen-Glucose Deprivation in Brain Cortical Cells.
Varlamova EG; Gudkov SV; Plotnikov EY; Turovsky EA
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806466
[TBL] [Abstract][Full Text] [Related]
13. The Synergistic Cytotoxic Effect of Laser-Irradiated Gold Nanoparticles and Sorafenib Against the Growth of a Human Hepatocellular Carcinoma Cell Line.
Ebrahim HM; El-Rouby MN; Morsy ME; Said MM; Ezz MK
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3369-3376. PubMed ID: 31759361
[TBL] [Abstract][Full Text] [Related]
14. Delivery of Sesamol Using Polyethylene-Glycol-Functionalized Selenium Nanoparticles in Human Liver Cells in Culture.
Liu F; Liu H; Liu R; Xiao C; Duan X; McClements DJ; Liu X
J Agric Food Chem; 2019 Mar; 67(10):2991-2998. PubMed ID: 30779555
[TBL] [Abstract][Full Text] [Related]
15. Poly-L-Lysine-Lactobionic Acid-Capped Selenium Nanoparticles for Liver-Targeted Gene Delivery.
Naidoo S; Daniels A; Habib S; Singh M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163414
[TBL] [Abstract][Full Text] [Related]
16. Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles.
Grillone A; Riva ER; Mondini A; Forte C; Calucci L; Innocenti C; de Julian Fernandez C; Cappello V; Gemmi M; Moscato S; Ronca F; Sacco R; Mattoli V; Ciofani G
Adv Healthc Mater; 2015 Aug; 4(11):1681-90. PubMed ID: 26039933
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cell permeabilization apoptosis-inducing activity of selenium nanoparticles by ATP surface decoration.
Zhang Y; Li X; Huang Z; Zheng W; Fan C; Chen T
Nanomedicine; 2013 Jan; 9(1):74-84. PubMed ID: 22542821
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Ca
Turovsky EA; Varlamova EG
Biology (Basel); 2021 Aug; 10(8):. PubMed ID: 34439975
[TBL] [Abstract][Full Text] [Related]
19. PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2.
Varshosaz J; Raghami F; Rostami M; Jahanian A
J Liposome Res; 2019 Dec; 29(4):383-398. PubMed ID: 30668221
[TBL] [Abstract][Full Text] [Related]
20. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
